Preventing the Development of Venous Insufficiency in Pregnant Women Through Use of Compression Stockings
1 other identifier
interventional
44
1 country
1
Brief Summary
Problem: Approximately 4 million live births occur in the United States each year. Pregnancy causes many physical changes in the mother, including venous distension, increased ability to form blood clots, and hormonal changes. Data suggest that these factors help cause venous insufficiency (when the veins do not adequately return blood from the extremities to the torso). As venous insufficiency progresses, complications follow, the most severe of which include superficial thrombophlebitis and deep venous thrombosis (DVT, or blood clots). Although the fear of DVT has been well publicized, its prevention and prevalence in pregnant women has not been well-studied. The exact cause of venous insufficiency is not known. However, known risk factors include being female and hormonal changes associated with oral contraceptive use, certain hormone replacement medications, and pregnancy. Being pregnant places the mother at additional risk for developing venous insufficiency. Compression stockings are used to manage the condition, but this is by no means standard of care despite their easy use and safety. The medical community's understanding of how compression stockings work is largely theoretical; however, it is believed that the compression works by preventing venous hypertension in the lower legs, thereby preventing venous insufficiency and its associated complications. Research hypothesis: The investigators hypothesize that compression stocking use will be associated with lower incidence of varicose veins and, in those patients who already have varicose veins, lower incidence of complications associated with venous insufficiency. Further, the investigators believe that compression stocking use will be associated with a lower incidence or lessening of symptoms associated with venous insufficiency. Importance: An undetected DVT can be fatal. Even if detected promptly, DVT is associated with long term health problems. Treatment of a DVT requires anticoagulation which can be risky to both mother and fetus. The prevention or reduction of DVT in pregnant women through use of compression stockings would revolutionize their care. Further, this intervention is safe and noninvasive. The investigators propose to conduct a randomized, pilot study comparing pregnant women without and with varicose veins randomized to wear compression stockings to a similar group of participants randomized to no compression stocking use.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2012
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2012
CompletedFirst Submitted
Initial submission to the registry
February 14, 2013
CompletedFirst Posted
Study publicly available on registry
February 15, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 24, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
August 24, 2014
CompletedJanuary 29, 2018
January 1, 2018
2.6 years
February 14, 2013
January 25, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Incidence of varicose veins
In pregnant women who do not have varicose veins (Group 1): To quantify and compare the incidence of varicose veins between participants randomized to the compression stocking use group (Group 1A) and those randomized to the no compression stocking use group (Group 1B).
8 weeks post-partum
Incidence of superficial thrombophlebitis and DVT
In pregnant women who already have varicose veins (Group 2): To quantify and compare the incidence of superficial thrombophlebitis and DVT between those randomized to the compression stocking use group (Group 2A) and those randomized to the no compression stocking use group (Group 2B).
8 weeks post-partum
Secondary Outcomes (1)
Incidence of symptoms of venous insufficiency
8 weeks post-partum
Study Arms (2)
No Stocking Use
NO INTERVENTIONFor pregnant women randomized to the no stocking use group, no compression stockings will be worn.
Compression Stocking Use
EXPERIMENTALPatients who are randomized to the stocking use group (Treatment Subgroup A) will be formally measured for their stockings by a certified stocking fitter, given (at no charge) two pair of 20-30mmg Hg maternity pantyhose compression stockings, and will undergo a brief tutorial regarding how to put the stockings on. Each patient will be instructed to wear the stockings on a daily basis, during the day.
Interventions
20-30mmg Hg maternity pantyhose compression stockings
Eligibility Criteria
You may qualify if:
- Pregnant women 18-45 years of age.
- Fetal gestation between 8-20 weeks.
- Patient is seeking care for the pregnancy at one of the study locations (Johns Hopkins East Baltimore Campus, Johns Hopkins Bayview Medical Center, and Johns Hopkins at White Marsh).
- Ability to complete informed consent and willingness to comply with protocol (return for all follow-up visits \& participate in phone interviews).
You may not qualify if:
- Inability to wear compression stockings.
- Women who currently have been prescribed to wear compression stockings by a medical professional.
- Chronic dermatological condition (i.e. psoriasis).
- Chronic deep vein thrombus or chronic phlebitis.
- In women with varicose veins: Presence of primary outcome (superficial thrombophlebitis or DVT) on first visit ultrasound.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Johns Hopkins Universitylead
- Sigvaris Corporationcollaborator
Study Sites (1)
Johns Hopkins Bayview Medical Center and Johns Hopkins Hospital
Baltimore, Maryland, 21224, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jennifer Heller, MD
Div. of Vascular Surgery, Johns Hopkins University School of Medicine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 14, 2013
First Posted
February 15, 2013
Study Start
February 1, 2012
Primary Completion
August 24, 2014
Study Completion
August 24, 2014
Last Updated
January 29, 2018
Record last verified: 2018-01